Colony-stimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis

Author:

Wiktor-Jedrzejczak W1,Dzwigala B1,Szperl M1,Maruszynski M1,Urbanowska E1,Szwech P1

Affiliation:

1. Department of Immunology, Central Clinical Hospital, Military School of Medicine, Warsaw, Poland.

Abstract

Osteopetrotic op/op mice have less than 5% of the normal number of macrophages in the peritoneal cavity (W. Wiktor-Jedrzejczak, A. Ahmed, C. Szczylik, and R.R. Skelly, J. Exp. Med. 156:1516-1527, 1982). Fecal peritonitis was induced by intraperitoneal injection of 0.5 ml of 5% autoclaved feces in saline along with Escherichia coli grown from feces of mice of the same colony and added in doses ranging between 10 and 10(6) CFU. Such infection led to a septic shock and either was lethal within 24 h or became cured without additional treatment of the mice. The op/op mice survived administration of 30-times-smaller doses of bacteria compared with their normal littermates. Analysis of the kinetics of cellular changes in the peritoneal cavity associated with such infection revealed that this increased susceptibility of macrophage-deficient mice cannot be explained by a direct role of macrophages in combating the infection. Instead, it appeared that the increased susceptibility to fatal fecal peritonitis was most likely due to delayed and impaired recruitment of neutrophils to the site of infection in mutant mice. The increased susceptibility of the op/op mice to E. coli fecal peritonitis was not due to their possible increased sensitivity to endotoxin, since the mutant mice tolerated lipopolysaccharide doses more than twice those tolerated by control littermates. On the other hand, their susceptibility to exogenous tumor necrosis factor alpha and interleukin-1 alpha was increased. Both mutant op/op and control mice were able to survive secondary challenge with 10(6) E. coli (administered along with feces) lethal for both types of mice on primary challenge. These data suggest that colony-stimulating factor 1-dependent resident peritoneal macrophages play a role in controlling primary infection by recruiting neutrophils and are not required for efficient response to secondary infection.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Reference26 articles.

1. Factors influencing the outcome of E. coli peritonitis in rats;Andersson R.;Acta Chir. Scand.,1989

2. Auger M. J. and J. A. Ross. 1992. The biology of the macrophage p. 1-74. In C. E. Lewis and J. O. McGee (ed.) The macrophage. IRL Press Oxford.

3. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin;Beutler B.;Science,1985

4. Effects of interleukin-1 on bone turnover in normal mice;Boyce B. F.;Endocrinology,1989

5. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse;Cecchini M. G.;Development,1994

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mononuclear phagocytes of the intestine, the skin, and the lung;Immunological Reviews;2014-10-15

2. Macrophages in Sepsis Progression;Macrophages: Biology and Role in the Pathology of Diseases;2014

3. Role of Macrophage Colony-Stimulating Factor in Polymicrobial Sepsis According to Studies Using Osteopetrotic (op/op) Mice;Journal of Surgical Research;2011-07

4. IL-18 Stimulates CSF-1 Expression via MyD88-dependent Pathway*;PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS;2011-06-15

5. CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses;The Journal of Immunology;2011-01-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3